Cysteine‐rich 61 (Cyr61) derived from adipose‐derived stem cells (ADSCs) promotes colorectal cancer (CRC) metastasis and vasculogenic mimicry via binding to the integrin αVβ5 receptor and activating the FAK signaling pathway. Here, CCN1 is linked to colorectal cancer.